Physician profile
Sukesh Burjonroppa
NPI 1467599134
$130,118.90
in general payments reported to CMS, 2019-2025
24 companies · $5,948 in 2025
The $5,948 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $21K · 2021: $25K · 2022: $20K · 2023: $15K · 2024: $4,666 · 2025: $5,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $14K · Travel and Lodging: $6,558 · Food and Beverage: $5,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,875.00 |
| Travel and Lodging | $6,558.21 |
| Food and Beverage | $5,283.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $59,012.53 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Medtronic Vascular, INC. | $55,977.24 | 2019-2020 | |
| Abbott Laboratories | $6,784.84 | 2019-2025 | Mitraclip, Quadra Allure Mp, Gallant |
| Edwards Lifesciences Corporation | $4,314.22 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Evoque |
| Boston Scientific Corporation | $956.46 | 2019-2025 | Watchman Flx, Bodyguardian |
| Abiomed | $946.21 | 2019-2025 | Impella |
| Siemens Medical Solutions USA, INC. | $887.65 | 2023 | |
| Biotronik INC. | $249.87 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $205.75 | 2019-2024 | |
| Heartflow, INC. | $133.53 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $116.27 | 2019-2025 | Camzyos |
| Shockwave Medical, INC | $112.02 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Pfizer INC. | $103.26 | 2020-2023 | |
| Janssen Pharmaceuticals, INC | $78.95 | 2020-2023 | Xarelto |
| Philips North America LLC | $34.35 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $33.10 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.07 | 2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $24.73 | 2019 | |
| Teleflex LLC | $24.13 | 2024 | Turnpike |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.83 | 2023 | Lifevest |
| Kiniksa Pharmaceuticals, LTD. | $20.71 | 2023 | Arcalyst |
| Avinger INC. | $18.77 | 2022 | |
| Astellas Pharma US INC | $17.37 | 2019 | |
| Amarin Pharma, INC. | $13.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sukesh Burjonroppa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.